Reply  by Zegdi, Rachid et al.
I
T
V
P
G
W
a
a
o
v
a
i
a
s
T
o
c
e
i
t
s
r
b
s
f
m
s
r
e
f
t
s
v
v
(
t
n
a
i
s
m
*
G
A
Journal of the American College of Cardiology Vol. 53, No. 2, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
Published by Elsevier Inc.CORRESPONDENCELetters to the Editor
*
U
2
3
I
E
R
1
2
3
4
5
R
W
m
(
s
a
i
p
i
t
v
s
i
d
t
s
ls it Reasonable to
reat All Calcified Stenotic
alves With a Valve Stent?
robably Yes If We
et a Full Stent Expansion
e read with interest the article by Zegdi et al. (1) regarding the
ppropriateness of percutaneous valve implantation in calcified
ortic valve stenosis. The study evaluated the behavior of intra-
perative valved stent implantation inside human stenotic aortic
alves before surgical valve replacement. The investigators reported
stent misdeployment, with an elliptical or triangular stent shape,
n a large number of tricuspid (32%) and in all bicuspid valves,
ccounting for variable gaps at the commissures level between the
tent’s external surface and the inner surface of native valve (1).
his finding represents the proof of concept of perivalvular leak
bserved early after percutaneous valve implantation in human
alcified aortic valves (2,3). In addition, the investigators hypoth-
sized that stent misdeployment and consequent valve distortion,
ncreasing the stress on valve leaflets, may lead to premature leaflets
ears or fibrosis and valve dysfunction (1).
In our opinion, some concerns exist about the results of this
tudy. First, the intraoperative model may be not completely
epresentative of the self-expandable valved stent behavior in the
eating heart. In this regard, the deployment of the self-expanding
tent continues for a long run after the implantation, as the nitinol
rames get back to the original shape and dimensions (4). This
echanism may explain the reduction in perivalvular leaks ob-
erved over time after self-expandable aortic valve implantation, as
ecently reported by Grube et al. (2). To the contrary, in the
xperience reported by Zegdi et al. (1) the stent remained in place
or no more than 2 min, so the investigators lacked the opportunity
o evaluate the device after full stent expansion. Moreover, the
tents were implanted in calcified aortic valves without balloon
alvuloplasty (1), which is common practice before percutaneous
alve implantation (2,3). Indeed, as acknowledged by Zegdi et al.
1), pre-dilation with appropriate balloons, providing fragmenta-
ion of the leaflets calcification (5), may improve the pliability of
ative valve leaflets and, therefore, favor the circular deployment
nd stent apposition to the aortic wall. We strongly believe these
ssues should be addressed to definitely establish the behavior of
elf-expanding stent-based percutaneous bioprosthesis in the hu-
an heart.
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eply
e thank Dr. Napodano and colleagues for their valuable com-
ents and their efforts to make our study more comprehensible
1). One should remark that the title of their letter implicitly
uggests that adequate stent expansion is an important goal to be
chieved during percutaneous valve implantation.
A major finding from our study was that stent expansion was
nappropriate in all bicuspid aortic valves. From a purely geometric
oint of view, getting a full stent expansion in this type of anatomy
s elusive because the length of the leaflet’s margins is always lower
han the circumference of the aortic orifice (in tricuspid aortic
alves, these 2 lengths are close). The usual elliptical aspect of the
tent in this clinical setting is attributable to the high leaflet rigidity
n this disease, a fact well-known by surgeons (and typically
epicted in Fig. 1 of our article [1]).
We completely agree with Napodano and colleagues on the fact
hat stent deployment in an arrested heart during 2 min (as in our
tudy) may not reflect stent deployment in a beating heart in the
ong run. Perivalvular leak may regress, but this needs better
haracterization. If one assumes that stent expansion is a contin-
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January 13, 2009:219–20ous process after valved stent deployment, then the prosthetic
alve orifice is expected to increase with time (irrespective of the
resence or absence of perivalvular leaks). In a recent study with
etailed measurements of aortic valve function, the post-procedural
ortic valve area remained stable during the first post-operative
onth, except in 1 case (with a poor initial result) (2).
To improve patients’ management, further clinical investiga-
ions on the true incidence of stent misdeployment and its clinical
mpact on valve function and durability are required.
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